NM_002880.4:c.681-37C>T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_002880.4(RAF1):​c.681-37C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00347 in 1,602,452 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 10 hom. )

Consequence

RAF1
NM_002880.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.984

Publications

0 publications found
Variant links:
Genes affected
RAF1 (HGNC:9829): (Raf-1 proto-oncogene, serine/threonine kinase) This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]
RAF1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
  • dilated cardiomyopathy 1NN
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LEOPARD syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-12604326-G-A is Benign according to our data. Variant chr3-12604326-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 258853.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 301 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002880.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
NM_002880.4
MANE Select
c.681-37C>T
intron
N/ANP_002871.1
RAF1
NM_001354689.3
c.681-37C>T
intron
N/ANP_001341618.1
RAF1
NM_001354690.3
c.681-37C>T
intron
N/ANP_001341619.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
ENST00000251849.9
TSL:1 MANE Select
c.681-37C>T
intron
N/AENSP00000251849.4
RAF1
ENST00000687505.1
n.762C>T
non_coding_transcript_exon
Exon 1 of 11
RAF1
ENST00000442415.7
TSL:5
c.681-37C>T
intron
N/AENSP00000401888.2

Frequencies

GnomAD3 genomes
AF:
0.00198
AC:
301
AN:
152154
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00370
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00171
AC:
393
AN:
229158
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.000402
Gnomad AMR exome
AF:
0.0000959
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00122
Gnomad NFE exome
AF:
0.00343
Gnomad OTH exome
AF:
0.00175
GnomAD4 exome
AF:
0.00363
AC:
5258
AN:
1450180
Hom.:
10
Cov.:
30
AF XY:
0.00349
AC XY:
2518
AN XY:
720490
show subpopulations
African (AFR)
AF:
0.000660
AC:
22
AN:
33332
American (AMR)
AF:
0.000118
AC:
5
AN:
42334
Ashkenazi Jewish (ASJ)
AF:
0.000116
AC:
3
AN:
25860
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39486
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84882
European-Finnish (FIN)
AF:
0.00144
AC:
76
AN:
52918
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.00455
AC:
5035
AN:
1105608
Other (OTH)
AF:
0.00188
AC:
113
AN:
60016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
253
507
760
1014
1267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00198
AC:
301
AN:
152272
Hom.:
0
Cov.:
32
AF XY:
0.00210
AC XY:
156
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41554
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00371
AC:
252
AN:
68016
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00158
Hom.:
0
Bravo
AF:
0.00181

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.8
DANN
Benign
0.65
PhyloP100
0.98
PromoterAI
0.0051
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191998453; hg19: chr3-12645825; API